Treating diabetic nephropathy - Are there only economic issue?

New England Journal of Medicine

Volumn 351, Issue 19, 2004, Pages 1934-1936

  Mitch, William E ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; TELMISARTAN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIALYSIS; DIET THERAPY; DISEASE COURSE; DRUG CHOICE; DRUG COST; DRUG MECHANISM; DRUG USE; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KINESIOTHERAPY; MEDICARE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SHORT SURVEY; SODIUM RESTRICTION; WEIGHT REDUCTION;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; HYPERTENSION; RECEPTORS, ANGIOTENSIN; UNITED STATES;

EID: 7444229870     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp048254     Document Type: Short Survey

References (5)

1. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.
2. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.
3. de Zeeuw D, Remuzzi G, Parving H-H, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004;110:921-7.
4. Idem. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004;65:2309-20.
5. Lewis EJ, Lewis JB. ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner? J Am Soc Nephrol 2004;15:1358-60.